Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.
Fast Thinking Teen Saves Church Leader from Anaphylaxis with Skills Learned in Health Class
Dietz saw the leader's condition was deteriorating quickly and knew action had to be taken immediately.
Infant Anaphylaxis Generally Resolves with Single Dose of Epinephrine, Seldom Requires Hospitalization
Researchers analyzed the medical records of 169 infants aged 0-24 months.
Mom Rushing Anaphylactic Son to Hospital was Pulled Over by Police. That’s When Providence...
A great story of tragedy averted.
Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy
According to research presented at this year's #ACAAI22 meeting.
Needle-Free, Sublingual Epinephrine Film Works Faster Than Auto-Injectors According to Study
Results from a 12mg formulation were comparable to intramuscular administration.
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3 Trial
Assessment for both single agent and add-on therapy.
Thousands of Allergy-Friendly Products in This Update of Allergence and the Safe Snack Guides!
Just in time for Thanksgiving cooking, baking, and entertaining!
Class Action Lawsuit Against SpoonfulONE Alleges Products Contain Insufficient Quantities of Proteins
Product is intended to introduce allergens to infants in order to decrease likelihood of developing allergies later in life.
Most Adults Achieve Food Allergy Desensitization with Oral Immunotherapy
But rates were lower than those for children and adolescents.
An Example of the Ridicule Kids with Food Allergies Face on Social Media
Social media has turned the entire world into one giant middle school.
